Literature DB >> 7380562

Comparative antigenicity and immunogenicity of A/USSR/77 influenza vaccines in normal and primed mice.

C McLaren, G E Grubbs, E Staton, W Barthlow, G Quinnan, F A Ennis.   

Abstract

In response to the threat of wide-spread epidemics of influenza in the United States due to the A/USSR/77 strain of virus, vaccines containing A/USSR/77 virus were prepared by four manufacturers. The vaccines were standardized by immunological measurements of viral hemagglutinin and were tested for their ability to induce serum hemagglutination-inhibiting antibodies in mice and to protect the animals against challenge infection with A/USSR/77 virus. Whole-virus and subunit virus vaccines were found to be equally efficacious, in contrast to our previous findings with vaccines prepared from other influenza virus strains. The effect of priming animals by infection with representative viruses of earlier eras on their response to A/USSR/77 vaccines was also studied. Enhanced responses were noted to both subunit and whole-virus A/USSR/77 vaccines in animals primed with viruses prevalent before 1957; higher antibody titers were induced with the subunit vaccine. A high degree of heterologous protection to A/USSR/77 challenge infection was found in mice primed with virus strains having hemagglutinin antigens unlike those of A/USSR/77 virus. Comparison of the responses of mice with those of humans inoculated with the same vaccines showed a similarity in many instances, with higher responses in those individuals primed with H0N1 and H1N1 viruses than in younger vaccinees.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380562      PMCID: PMC550908          DOI: 10.1128/iai.28.1.171-177.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses.

Authors:  H J Zweerink; S A Courtneidge; J J Skehel; M J Crumpton; B A Askonas
Journal:  Nature       Date:  1977-05-26       Impact factor: 49.962

2.  Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72.

Authors:  F A Ennis; M A Wells; D W Barry; S Daniel; J Manischewitz
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

3.  Immunity to influenza in ferrets. 13. Protection against influenza infection by serum antibody to homologous haemagglutinin or neuraminidase antigens.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

4.  Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice.

Authors:  D W Barry; E Staton; R E Mayner
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

5.  Quantitation of influenza vaccine hemagglutinin by immunoelectrophoresis.

Authors:  R E Mayner; R J Blackburn; D W Barry
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

6.  [Heterotypic crossed immunity, in the mouse, between human influenza viruses of types A and A 2].

Authors:  G H Werner
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1966-12-07

7.  Immunity to influenza in ferrets. XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  J Hyg (Lond)       Date:  1974-12

8.  Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens.

Authors:  F A Ennis; W J Martin; M W Verbonitz; G M Butchko
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

9.  Problems of influenza virus vaccine standardization.

Authors:  N M Tauraso; T C O'Brien; E B Seligman
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

10.  Experimental transmission of influenza virus infection in mice. 3. Differing effects of immunity induced by infection and by inactivated influenza virus vaccine on transmission of infection.

Authors:  J L Schulman
Journal:  J Exp Med       Date:  1967-03-01       Impact factor: 14.307

View more
  2 in total

1.  The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus.

Authors:  E T Ben Ahmeida; R Jennings; M Erturk; C W Potter
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  The antigenicity of whole virus versus subunit trivalent influenza vaccines -- a field trial in the Israel Defence Forces, 1978.

Authors:  J D Kark; M Lebiush; L Rannon; E Witztum; E Nili; R Kedem
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.